DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

University of Aarhus100 enrolled

Overview

Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Conditions

Head and Neck Neoplasms Recurrence Neoplasms, Second Primary

Interventions

RadiotherapyPROCEDURE

20 Gy in 4 fx

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Incurable primary or second primary head and neck cancer * Speaks and reads Danish * Capable of filling out questionnaires for at leas two months after radiotherapy * Age\>=18 years * Expected survival\> 3months

Locations (1)

Department of Oncology

Aarhus, Denmark

Outcomes

Primary Outcomes

Frequency and intensity of symptoms before and after radiotherapy (EORTC C30 and H&N35 questionnaires and CTC AE 3.0 toxicity scores)

Time frame: 11 mths

Secondary Outcomes

Survival

Time frame: 11 mths

Side effects

Time frame: 2 mths

Other treatments

Time frame: 11 mths

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.